Detalles de la búsqueda
1.
Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN.
Br J Cancer
; 130(1): 73-81, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37951974
2.
Development and Optimization of a Subtraction-Normalized Immunocyte Profiling Signature for Prostate Cancer Active Surveillance Risk Stratification.
J Urol
; 211(3): 415-425, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38147400
3.
Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial.
J Urol
; 212(1): 74-86, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38704840
4.
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.
Lancet Oncol
; 22(1): 107-117, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33253641
5.
Longitudinal follow-up and performance validation of an mRNA-based urine test (Xpert® Bladder Cancer Monitor ) for surveillance in patients with non-muscle-invasive bladder cancer.
BJU Int
; 128(6): 713-721, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33793062
6.
Optimizing the management of castration-resistant prostate cancer patients: A practical guide for clinicians.
Prostate
; 80(14): 1159-1176, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32779781
7.
Development and evaluation of a bladder Cancer specific survivorship care plan by patients and clinical care providers: a multi-methods approach.
BMC Health Serv Res
; 20(1): 686, 2020 Jul 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32709234
8.
Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials.
BMC Urol
; 18(1): 77, 2018 Sep 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30189902
9.
Correction to: Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials.
BMC Urol
; 18(1): 84, 2018 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30285696
10.
Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical Trial.
JAMA
; 319(18): 1880-1888, 2018 05 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29801011
11.
Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials.
Clin Cancer Res
; 29(13): 2426-2434, 2023 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37058234
12.
Post Hoc Analysis of Rapid and Deep Prostate-specific Antigen Decline and Patient-reported Health-related Quality of Life in SPARTAN and TITAN Patients with Advanced Prostate Cancer.
Eur Urol Oncol
; 2023 Dec 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38072759
13.
Enzalutamide versus bicalutamide in patients with nonmetastatic castration-resistant prostate cancer: a prespecified subgroup analysis of the STRIVE trial.
Prostate Cancer Prostatic Dis
; 25(2): 363-365, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34621011
14.
Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non-muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical Trial.
Eur Urol
; 81(3): 223-228, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34933753
15.
Androgen Receptor Splice Variant, AR-V7, as a Biomarker of Resistance to Androgen Axis-Targeted Therapies in Advanced Prostate Cancer.
Clin Genitourin Cancer
; 18(1): 1-10, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31653572
16.
Variability in adherence to guidelines based management of nonmuscle invasive bladder cancer among Society of Urologic Oncology (SUO) members.
Urol Oncol
; 38(10): 796.e1-796.e6, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32430255
17.
A 17-gene Panel for Prediction of Adverse Prostate Cancer Pathologic Features: Prospective Clinical Validation and Utility.
Urology
; 126: 76-82, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30611659
18.
Absorbable Hydrogel Spacer Use in Prostate Radiotherapy: A Comprehensive Review of Phase 3 Clinical Trial Published Data.
Urology
; 115: 39-44, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29174940
19.
Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting.
Prostate Cancer Prostatic Dis
; 21(1): 78-84, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29158509
20.
Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.
J Clin Oncol
; 36(4): 414-424, 2018 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29236593